mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |